JPRN-UMIN000017410已完成未知
Safety and Efficacy of Protocol for Shortening the Duration of Dual Antiplatelet Therapy after Second and Third Generation Drug Eluting Stent Implantation in Patients Administered Oral Anticoagulant Agent - Safety and Efficacy of Protocol for Shortening the Duration of Dual Antiplatelet Therapy after Second and Third Generation Drug Eluting Stent Implantation in Patients Administered Oral Anticoagulant Agent
Sendai Kousei Hospital0 个研究点目标入组 285 人开始时间: 2015年5月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 285
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who could not tolerate antiplatelet therapy or anticoagulation therapy 2. Patients who appeared to be inappropriate for this study, determined by the investigators
研究者
相似试验
招募中
4 期
The investigation of safety and efficacy of short hydration GC therapy in metastatic urothelial carcinoma patientsadvanced or metastatic urothelial carcinoma patientsJPRN-UMIN000032901agoya City University Graduate School of Medical Sciences10
尚未招募
3 期
Evaluation of the Safety and Efficacy of Short-term A 002 Treatment in Subjects with Acute Coronary SyndromesHeart AttackHeart Disease10082206NL-OMON34504Anthera Pharmaceuticals, Inc576
进行中（未招募）
不适用
Evaluation of the Safety and Efficacy of Short-term A-002 Treatment in Subjects with Acute Coronary Syndromes - VISTA-16Treatment of patients with Acute Coronary Syndromes (ACS)MedDRA version: 12.1Level: LLTClassification code 10051592Term: Acute coronary syndromeEUCTR2009-016812-18-CZAnthera Pharmaceuticals, Inc.6,504
进行中（未招募）
不适用
Evaluation of the Safety and Efficacy of Short-term A-002 Treatment in Subjects with Acute Coronary Syndromes - VISTA-16Treatment of patients with Acute Coronary Syndromes (ACS)MedDRA version: 12.1Level: LLTClassification code 10051592Term: Acute coronary syndromeEUCTR2009-016812-18-DEAnthera Pharmaceuticals, Inc.6,504
进行中（未招募）
不适用
Evaluation of the Safety and Efficacy of Short-term A-002 Treatment in Subjects with Acute Coronary Syndromes (VISTA-16) - VISTA-16Acute Coronary SyndromesMedDRA version: 9.1Level: LLTClassification code 10051592EUCTR2009-016812-18-ITANTHERA PHARMACEUTICALS6,504